Diagnosing and treating alzheimer's disease

A method of treating a subject having Alzheimer's disease can include assaying a biological medium obtained from the subject for a biomarker selected from the group consisting of Biomarker 1, Biomarker 2, Biomarker 3, Biomarker 4, Biomarker 5, Biomarker 6, Biomarker 7, Biomarker 8, Biomarker 9,...

Full description

Saved in:
Bibliographic Details
Main Author Graves, Steven William
Format Patent
LanguageEnglish
Published 08.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method of treating a subject having Alzheimer's disease can include assaying a biological medium obtained from the subject for a biomarker selected from the group consisting of Biomarker 1, Biomarker 2, Biomarker 3, Biomarker 4, Biomarker 5, Biomarker 6, Biomarker 7, Biomarker 8, Biomarker 9, Biomarker 10, Biomarker 11, and combinations thereof, where Biomarker 1 has a mass-to-charge ratio (m/z) of 229.13, Biomarker 2 has a m/z of 514.38, Biomarker 3 has a m/z of 602.44, Biomarker 4 has a m/z of 620.42, Biomarker 5 has a m/z of 630.47, Biomarker 6 has a m/z of 703.56, Biomarker 7 has a m/z of 724.52, Biomarker 8 has a m/z of 778.54, Biomarker 9 has a m/z of 799.66, Biomarker 10 has a m/z of 824.60, and Biomarker 11 has a m/z of 842.61. The method can also include relating a characteristic of the biomarker to a presence of Alzheimer's disease in the subject and treating the subject for Alzheimer's disease.
Bibliography:Application Number: US201716316007